The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/pn.39.7.0066
psychnewsPsychiatr NewsPsychiatric NewsNewspaper of the American Psychiatric AssociationPsychiatr NewsPsychiatr News0033-27041559-1255American Psychiatric Association
242004

Dr. Goin responds:

As active as APA is in the realm of public policy, it is difficult for any one column or article to mention all of our efforts to advance psychiatry and the care of our patients. I am grateful to Dr. Abramson for the opportunity to reiterate APA’s role in supporting necessary changes to our nation’s antitrust laws.

For several years now, APA has worked in collaboration with the American Medical Association and other medical societies for passage of specific legislation to enable physicians to deal effectively with insurers—and without fear of violating antitrust laws. Our most recent lobbying effort is on behalf of HR 1120, the Health Care Antitrust Improvements Act of 2003, which would give physicians greater power in negotiating with insurance companies.

As Dr. Abramson says, correcting the law is an uphill battle, but APA is firm in its commitment to this bill, which now has 15 cosponsors in the House of Representatives. I will update you as APA secures more cosponsors and takes every step necessary to achieve a level playing field.